Citadel Advisors’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,140
Closed -$9K 6895
2022
Q3
$9K Buy
+1,140
New +$9K ﹤0.01% 5659
2022
Q2
Hold
0
7152
2022
Q1
Sell
-1,476
Closed -$83K 7324
2021
Q4
$83K Buy
+1,476
New +$83K ﹤0.01% 5999
2021
Q3
Sell
-1,384
Closed -$133K 7281
2021
Q2
$133K Buy
1,384
+698
+102% +$67.1K ﹤0.01% 5826
2021
Q1
$101K Sell
686
-1,406
-67% -$207K ﹤0.01% 5849
2020
Q4
$293K Buy
2,092
+755
+56% +$106K ﹤0.01% 4255
2020
Q3
$203K Sell
1,337
-144
-10% -$21.9K ﹤0.01% 4084
2020
Q2
$260K Buy
+1,481
New +$260K ﹤0.01% 3906
2020
Q1
Sell
-591
Closed -$85K 5439
2019
Q4
$85K Buy
+591
New +$85K ﹤0.01% 4318
2019
Q1
Sell
-478
Closed -$16K 5152
2018
Q4
$16K Buy
478
+433
+962% +$14.5K ﹤0.01% 4329
2018
Q3
$3K Sell
45
-127
-74% -$8.47K ﹤0.01% 4223
2018
Q2
$14K Buy
172
+60
+54% +$4.88K ﹤0.01% 4092
2018
Q1
$10K Buy
+112
New +$10K ﹤0.01% 3917
2017
Q4
Sell
-64
Closed -$18K 4367
2017
Q3
$18K Buy
+64
New +$18K ﹤0.01% 3539
2017
Q1
Sell
-28
Closed -$17K 4279
2016
Q4
$17K Sell
28
-11
-28% -$6.68K ﹤0.01% 3480
2016
Q3
$45K Sell
39
-49
-56% -$56.5K ﹤0.01% 3304
2016
Q2
$96K Buy
88
+58
+193% +$63.3K ﹤0.01% 2969
2016
Q1
$39K Buy
30
+19
+173% +$24.7K ﹤0.01% 3042
2015
Q4
$28K Sell
11
-130
-92% -$331K ﹤0.01% 3553
2015
Q3
$155K Buy
141
+101
+253% +$111K ﹤0.01% 3266
2015
Q2
$40K Sell
40
-1
-2% -$1K ﹤0.01% 3480
2015
Q1
$41K Buy
+41
New +$41K ﹤0.01% 3421
2014
Q4
Sell
-23
Closed -$68K 4040
2014
Q3
$68K Sell
23
-5
-18% -$14.8K ﹤0.01% 3129
2014
Q2
$106K Buy
+28
New +$106K ﹤0.01% 2989